Table 2 Faecal carriage rate of CTXM, plasmid-mediated AmpC, and plasmid-mediated quinolone resistance alleles in 61 healthy people.
Antibiotic resistance alleles | % (number) | P for trend | |||
|---|---|---|---|---|---|
Total | HARG | MARG | LARG | ||
CTX-M | 23% (14) | 60% (6) | 17.1% (7) | 10% (1) | 0.008 |
CTX-M-1G | 11.5% (7) | 30% (3) | 7.3% (3) | 10% (1) | 0.164 |
CTX-M-9G | 16.4% (10) | 50% (5) | 12.2% (5) | 0% (0) | 0.003 |
Plasmid-mediatedAmpC | 16.4% (10) | 40% (4) | 12.2% (5) | 10% (1) | 0.072 |
CMY-1 | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
CMY-2 | 13.1% (8) | 20% (2) | 12.2% (5) | 10% (1) | 0.511 |
FOX | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
DHA | 3.3% (2) | 20% (2) | 0% (0) | 0% (0) | 0.013 |
Plasmid-mediatedquinolone resistance | 59% (36) | 60% (6) | 65.9% (27) | 30% (3) | 0.176 |
qnrA | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
qnrB | 44.3% (27) | 60% (6) | 43.9% (18) | 30% (3) | 0.18 |
qnrD | 4.9% (3) | 10% (1) | 4.9% (2) | 0% (0) | 0.213 |
qnrS | 54.1% (33) | 50% (5) | 61% (25) | 30% (3) | 0.373 |
qepA | 0% (0) | 0% (0) | 0% (0) | 0% (0) | |
aac(6′)-Ib-cr | 13.1% (8) | 10% (2) | 12.2% (5) | 10% (1) | 0.511 |
Total (median, [1Q, 3Q]) | 2 (0.8, 4.3) | 1 (0, 2) | 0 (0, 0.8) | 0.035* | |
